← Archive
N 50/2025 IN FORCE Import policy & restrictions ·?

Amendment in Import Policy Condition of Specific items covered under Chapter 29 of ITC (HS) 2022, Schedule-I (Import Policy)

Reliability

In force — no superseding record on file.

Document text

To be published in the Gazette of India Extraordinary Part-II, Section-3, Sub-Section (ii)

Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade Vanijya Bhawan, New Delhi Notification No. 50 /2025-26 New Delhi, Dated: 18" December, 2025

Subject: Amendment in Import Policy Condition of Specific items covered under Chapter 29 of ITC (HS) 2022, Schedule-I (Import Policy)-reg.

S.O. (E): In exercise of powers conferred by Section 3 and Section 5 of the Foreign Trade (Development & Regulation) Act, 1992, read with paragraphs 1.02 and 2.01 of the Foreign Trade Policy (FTP) 2023, as amended from time to time, the Central Government hereby makes the following amendments under Chapter 29 of ITC (HS), 2022, Schedule-I (Import Policy), with immediate effect.

  1. Policy Condition No.08 of Chapter 29 is introduced as under:

i. Import of diluted Potassium Clavulanate having a CIF value of less than USD 77 per KG, is 'Restricted' till 30.11.2026.

ii. Import ofPotassium Clavulanate having a CIF value of less than USD 180 per KGA, is 'Restricted' till 30.11.2026.

iii. Import of the following intermediates used for the manufacture of Clavulanic Acid or Potassium Clavulanate, having a CIF value below USD 92 per KG, shall be ‘Restricted’ till 30.11.2026:

==> picture [42 x 39] intentionally omitted <==

----- Start of picture text -----<br> AS<br>----- End of picture text -----<br>

USD 92 per KG, shall be ‘Restricted’ till 30.11.2026:

==> picture [42 x 39] intentionally omitted <==

----- Start of picture text -----<br> AS<br>----- End of picture text -----<br>

Tertiary Butylamine Salt — Potassium Clavulanate; Tertiary Butylamine Salt — Intermediate of Clavulanic Acid; Tertiary Octylamine Salt — Potassium Clavulanate; Tertiary Octylamine Salt — Intermediate of Clavulanic Acid;

iv. The provisions at Para (i), (ii) and (iii) above shall not apply to imports made by Advance Authorisation holders, Export Oriented Units (EOUs) and units in the SEZs, subject to the condition that the imported inputs are not sold into the Domestic Tariff Area (DTA).

  1. The Import Policy Condition for the following ITC (HS) Codes is amended as under:
|ITC(HS)Dison:<br>Code|(ie<br>Policy|sienPolicy<br>|Condition|RevisedPolicyCondition|
|---|---|---|---|
|29161930|Potassium|Free||Subject to Policy Condition No.|
|compounds of|||08 of Chapter 29.|
|unsaturated acyclic||||
|:<br>monoacids||||

!

ndition|RevisedPolicyCondition| |---|---|---|---| |29161930|Potassium|Free||Subject to Policy Condition No.| |compounds of|||08 of Chapter 29.| |unsaturated acyclic|||| |:<br>monoacids||||




! 

```text
||29163930 |Potassium|Free||-|Subject|to Policy Condition|to Policy Condition|No.|No.||
|---|---|---|---|---|---|---|---|---|---|
|‘|compounds of|||08 ofChapter 29.||||||
||aromatic monoacids|||||||||
||29163990 |Other|Free|ja) However, import of|a)|However,<br>import|||o||
||||ATS-8 {(4R-Cis)-1,1-||ATS-8<br>{(4R-Cis)-1,1-|||||
||||Dimethylethyl-6-||Dimethylethyl-6-|||||
||||cyanomethyl-2,2-||cyanomethyl-2,2-|||||
||||dimethyl-1- 3- dioxane-||dimethyl-1- 3- dioxane-|||||
||||4-acetate} having a CIF||4-acetate} having|a|CIF|||
||||value ofless than US$||value of less than||US$|||
||||111 per kg, is||111<br>per’<br>kg,|||is||
||||Restricted’ till||‘Restricted’|||till||
||||30.09.2026.||30.09.2026.|||||
|||||b)|Subject<br>to|Policy||||
||||||Condition<br>No.|08||o||
||||||Chapter 29.|||||
||29183090 |Carboxylic acids|Free||Subject|to Policy Condition||No.|||
||with aldehyde or|||08 ofChapter 29.||||||
||ketone function but|||||||||
||ithout otheroxygen|||||||||
||function, their|||||||||
||anhydrides, halides,|||||||||
||peroxides,|||||||||
||peroxyacids and thei||||,|||||
||derivatives: Other|||||||||
||29335990 |Other|Free||Subject|to Policy Condition||No.|||
|||||08 of Chapter 29.||||||
|De<br>i|29339990 |Other|Free|ja)However,importof<br>ATS-8 {(4R-Cis)-1,1-<br>Dimethylethyl-6-|a)|However, importof<br>ATS-8 {(4R-Cis)-1,1-<br>Dimethylethyl-6-|||||

No.|||
|||||08 of Chapter 29.||||||
|De<br>i|29339990 |Other|Free|ja)However,importof<br>ATS-8 {(4R-Cis)-1,1-<br>Dimethylethyl-6-|a)|However, importof<br>ATS-8 {(4R-Cis)-1,1-<br>Dimethylethyl-6-|||||
||||cyanomethyl-2,2-||cyanomethyl-2,2-|||||
||||dimethyl-1- 3- dioxane-||dimethyl-1- 3- dioxane-|||||
||||4-acetate} having a CIF||4-acetate} having|a|CIF|||
||||value ofless than US$||value ofless than|US$||||
||||111 per kg, is||111 per kg, is|||||
||||'Restricted' till||‘Restricted’ till|||||
||||30.09.2026.||30.09.2026.|||||
|||||b)|Subject to Policy|||||
||||||Condition No. 08|of||||
||||||Chapter 29.|||||
||29349990 Other|Free|(a) However, import of|a)|However, import|of||||
||||ATS-8 {(4R-Cis)-1,1-||ATS-8 {(4R-Cis)-1,1-<br>—|||||
||||Dimethylethyl-6-||Dimethylethyl-6-|||||
||||cyanomethyl-2,2-||cyanomethyl-2,2-|||||
||||dimethyl-1- 3- dioxane-||dimethyl-1- 3- dioxane-|||||.|
||||4-acetate} having aCIF||4-acetate} having a||CIF|||
||||value ofless than US$||value ofless than|US$||||
||||111 per kg, is<br>'Restricted' till||111 per kg, is<br>'Restricted' till|||||
||||30.09.2026.||30.09.2026.|||||

|

e} having a||CIF||| ||||value ofless than US$||value ofless than|US$|||| ||||111 per kg, is<br>'Restricted' till||111 per kg, is<br>'Restricted' till||||| ||||30.09.2026.||30.09.2026.|||||




| 

```text
|||||b)|Subject to Policy|
|---|---|---|---|---|---|
|'|||||Condition No. 08 of|
||||||Chapter 29.|
||29411030/Amoxicillin and its||Free||Subject|to Policy ConditionNo.|
||salts|||08 ofChapter 29.||
||29411090 |Other|Free||Subject|to Policy Condition No.|
|||||08 of Chapter 29.||
||29419019|Other Rifampicin|—_‘|Free||Subject|to Policy ConditionNo.|
||and Its Salts|||08 of Chapter 29.||
||29419090|Rifampicin and its||Free||Subject|to PolicyConditionNo.|
||salts: ---- Other|||08 ofChapter 29.||
||29420011|Cefadroxil and its|_‘|Free||Subject|to Policy Condition No.|
|a<br>—|salts<br>29420090|Diloxanide furoate,<br>cimetidine,<br>oxyclozanide,||Free|(a)However, importof<br>ATS-8 {(4R-Cis)-1,1-<br>Dimethylethyl-6-|08ofChapter29.<br>a) However,importof<br>ATS-8 {(4R-Cis)-1, 1-<br>Dimethylethyl-6-||
||famotidine : Other||cyanomethyl-2,2-||cyanomethyl-2, 2-|
||||dimethyl-1- 3- dioxane-||dimethyl-1- 3- dioxane-|
||||4-acetate} having aCIF||4-acetate} having aCIF|
||||value ofless than US$||value ofless than US$|
||||111 per kg, is||111 per kg, is|
||||'Restricted' till||'Restricted' till|
||||30.09.2026.||30.09.2026.|
|||||b)|Subject to Policy|
||||||Condition No. 08 of|
||||||Chapter29.|

Effect of the Notification:

Import of diluted Potassium Clavulanate, Potassium Clavulanate (KGA), and specified intermediates is subject to Policy Condition No. 8 of Chapter 29 of the ITC (HS), 2022, Schedule-I (Import Policy) with immediate effect, till 30.11.2026.

This is issued with the approval of the Minister of Commerce & Industry.

(Ajay Bhadoo) Addl. Secretary to Govt. of India & Director General of Foreign Trade Email: dgft@nic.in

[Issued from File No.01/89/180/69/AM-25/PC-2 (A)/ [E-44571.]

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 12179 --apply.

Citation copied